132 259

Cited 0 times in

Personalized medicine in breast cancer: a systematic review

Authors
 Sang-Hoon Cho  ;  Jongsu Jeon  ;  Seung Il Kim 
Citation
 JOURNAL OF BREAST CANCER, Vol.15(3) : 265-272, 2012 
Journal Title
 JOURNAL OF BREAST CANCER 
ISSN
 1738-6756 
Issue Date
2012
Keywords
Biomarker discovery ; Breast neoplasms ; Individualized medicine ; Predictive biomarker ; Prognostic biomarker
Abstract
The recent advent of "-omics" technologies have heralded a new era of personalized medicine. Personalized medicine is referred to as the ability to segment heterogeneous subsets of patients whose response to a therapeutic intervention within each subset is homogeneous. This new paradigm in healthcare is beginning to affect both research and clinical practice. The key to success in personalized medicine is to uncover molecular biomarkers that drive individual variability in clinical outcomes or drug responses. In this review, we begin with an overview of personalized medicine in breast cancer and illustrate the most encountered statistical approaches in the recent literature tailored for uncovering gene signatures.
Files in This Item:
T201205165.pdf Download
DOI
23091538
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Seung Il(김승일)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/90644
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links